Log in to search using one of your social media accounts:

 

Setback to Roche Hopes for Tecentriq as Fails Key Cancer Trial Setback to Roche Hopes for Tecentriq as Fails Key Cancer Trial
Roche's hopes of its Tecentriq (atezolizumab) immunotherapy catching rival medicines from Merck and Bristol-Myers Squibb were dealt a blow on Thursday after it failed a key combination trial.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 11, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Potential Role for Vaccines, Checkpoint Inhibitors in Chemoprevention of Lynch Syndrome
Researchers from MD Anderson say their study results " open the field of immunoprevention in LS to checkpoint inhibitors as an immune interception strategy. " (Source: CancerNetwork)
Source: CancerNetwork - May 11, 2018 Category: Cancer & Oncology Authors: Leah Lawrence Tags: Colorectal Cancer Gastrointestinal Cancer News Source Type: news

CRC Polyps May Allow for Immune Checkpoint Inhibitors in Premalignant Lesions
Colorectal carcinomas in LS patients appear in background of mismatch repair (MMR) deficiency, show a unique immune profile, and response to immunotherapy. (Source: CancerNetwork)
Source: CancerNetwork - May 11, 2018 Category: Cancer & Oncology Authors: Leah Lawrence Tags: Colorectal Cancer Gastrointestinal Cancer News Source Type: news

Many cancer docs OK medical pot despite lack of studies
Most oncologists say they don't know enough about medical marijuana to provide an informed opinion to patients, but many still give it their blessing, a new survey reveals (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - May 11, 2018 Category: Consumer Health News Source Type: news

Marriage may be good for catching melanoma early
(Reuters Health) - Married people may be more likely to spot a deadly skin cancer sooner than their counterparts who aren't part of a couple, a U.S. study of melanoma patients suggests. (Source: Reuters: Health)
Source: Reuters: Health - May 11, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Personalize Decisions on PSA Screening for Men Ages 55-69
On May 8, the U.S. Preventive Services Task Force posted its new final recommendation statement and three final evidence reviews on screening for prostate cancer, advising individual screening for men ages 55-69 and no screening for those who are older. (Source: AAFP News)
Source: AAFP News - May 11, 2018 Category: Primary Care Source Type: news

UCLA faculty voice: A hangover pill? Tests on drunk mice show promise
UCLAYunfeng LuYunfeng Lu is a professor of chemical and biomolecular engineering in the UCLA Samueli School of Engineerg.  Thiscolumn appeared in the Conversation.“Civilization begins with distillation,” said William Faulkner, a writer and drinker. Although ourthirst for alcohol dates back to the Stone Age, nobody has figured out a good way to deal with the ensuing hangover after getting drunk.As a chemical engineering professor and wine enthusiast, I felt I needed to find a solution. As frivolous as this project may sound, it has serious implications. Between 8 and10 percent of emergency room visits in Am...
Source: UCLA Newsroom: Health Sciences - May 11, 2018 Category: Universities & Medical Training Source Type: news

Uric Acid: Both High and Low are Hazardous
(MedPage Today) -- Increased risks of all-cause, cardiovascular, and cancer mortality (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - May 11, 2018 Category: Cardiology Source Type: news

Biotech buyout means happy returns for Kleiner Perkins
A small biotech's $1.6 billion buyout by Eli Lilly and Co. would create big Bay Area venture capital winners — including a 50x return for Kleiner Perkins Caufield& Byers — and could turn the cancer immunotherapy investing space white hot. Lilly (NYSE: LLY) will buy ARMO BioSciences Inc. (NASDAQ: ARMO) for $50 a share in an all-cash deal that is nearly triple the price of the Redwood City company's shares when it went public in January. That means big winners amo ng early investors who saw the… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - May 11, 2018 Category: Health Management Authors: Ron Leuty Source Type: news

How Math Can Potentially Reduce Unnecessary Breast Biopsies
The perceived risk of missing a breast cancer diagnosis with imaging studies often leads to unnecessary breast biopsies, according to a new report published in the American Journal of Roentgenology. The authors showed how statistical methods can be used to downgrade the risk classification of breast masses to reduce the need for unnecessary biopsies. Clinicians from San Antonio, TX-based Seno Medical and medical center collaborators from the University of Texas (MD Anderson and U of Texas Health Sciences Center) co-authored the report. The authors studied a statistical calculation known as the negative ...
Source: MDDI - May 11, 2018 Category: Medical Devices Authors: Amanda Pedersen Tags: Imaging Source Type: news

Talking About Pot with Cancer Patients
(MedPage Today) -- Discrepancy between oncologists'actions, knowledge (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - May 11, 2018 Category: Primary Care Source Type: news

A mom with terminal cancer sees her son graduate in a special hospital ceremony
Like many parents, Stephanie Northcott dreamed of the day she would get to see her son Dalton walk across the stage to receive his high school diploma. (Source: CNN.com - Health)
Source: CNN.com - Health - May 11, 2018 Category: Consumer Health News Source Type: news

Photopheresis: A cancer treatment that goes beyond skin deep
Shedding light on new uses for Photopheresis, a cellular immunotherapy developed by Yale Medicine ’s chair of dermatology, Dr. Richard Edelson. (Source: Yale Science and Health News)
Source: Yale Science and Health News - May 11, 2018 Category: Universities & Medical Training Source Type: news

A&E, RTT and cancer waits - April 2018: explore the maps
NHS waiting lists around England, updated for April 2018. (Source: HSJ)
Source: HSJ - May 11, 2018 Category: UK Health Source Type: news

ViewRay shares dip despite Q1 earnings Beat
Shares in ViewRay (NSDQ:VRAY) fell today despite the medical device maker posting first quarter earnings that beat expectations on Wall Street. The Cleveland-based company posted losses of $7.5 million, or 11¢ per share, on sales of $26.2 million for the three months ended March 31, seeing losses shrink 73% while sales grew over 2000% compared with the same period during the previous year. Losses per share were ahead of the 19¢ consensus on Wall Street, where analysts expected to see sales of $12.1 million, which the company handily topped. “During the first quarter we continued to build momentum by ge...
Source: Mass Device - May 11, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News MassDevice Earnings Roundup Wall Street Beat ViewRay Inc. Source Type: news

New At-Home CBC Device Enables Complete Blood Testing for Cancer Treatments and Biological/Viral Monitoring
Chronic disease monitoring at home has become a boon to patients as well as hospitals that are finding cost savings in programs designed to monitor/treat patients at external locations Many clinical pathologists and medical laboratory scientists will be wary about the news that a California company wants to have cancer patients do their own CBCs […] (Source: Dark Daily)
Source: Dark Daily - May 11, 2018 Category: Laboratory Medicine Authors: Jude Tags: Instruments & Equipment Laboratory Instruments & Laboratory Equipment Laboratory Management and Operations Laboratory Pathology Laboratory Testing Alfred Lin anatomic pathology Athelas CBC CLIA clinical laboratory Clinical Laboratory Source Type: news

Cancer Docs Seek More Study of Medical Marijuana
Seven out of 10 oncologists surveyed in the United States said they aren't informed enough about the risks and benefits of medical marijuana to recommend its use to patients, according to findings published May 10 in the Journal of Clinical Oncology. (Source: WebMD Health)
Source: WebMD Health - May 11, 2018 Category: Consumer Health News Source Type: news

Is This New Immunotherapy Biomarker Really'Ready for Primetime'? Is This New Immunotherapy Biomarker Really'Ready for Primetime'?
Drs West and Borghaei discuss the current state of tumor mutational burden as a potential biomarker for lung cancer.Medscape Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 11, 2018 Category: Consumer Health News Tags: Hematology-Oncology Commentary Source Type: news

KEYNOTE-189 Establishes New Lung Cancer Standard of Care KEYNOTE-189 Establishes New Lung Cancer Standard of Care
Thoracic oncologists Jack West, MD, and Hossein Borghaei, MD, discuss the real-world clinical implications of the KEYNOTE-189 trial of pembrolizumab in lung cancer.Medscape Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 11, 2018 Category: Consumer Health News Tags: Hematology-Oncology Commentary Source Type: news

Quantifying Cancer Risk in Patients With Glomerular Diseases Quantifying Cancer Risk in Patients With Glomerular Diseases
Dr Desai reviews a paper that presents a useful guide in quantifying cancer risk in patients with glomerular diseases.Medscape Nephrology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 11, 2018 Category: Consumer Health News Tags: Nephrology Viewpoint Source Type: news

Advanced Cancer Screening Garnering Attention at AUA Advanced Cancer Screening Garnering Attention at AUA
New diagnostic and predictive techniques for prostate and other cancers will figure prominently at the upcoming American Urological Association (AUA) 2018 Annual Meeting.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 11, 2018 Category: Consumer Health News Tags: Urology News Source Type: news

Big Peninsula biotech buyout means happy returns for Kleiner Perkins, other VCs
A small Peninsula biotech's $1.6 billion buyout by Eli Lilly and Co. would create big Bay Area venture capital winners — including a 50x return for Kleiner Perkins Caufield& Byers — and could turn the cancer immunotherapy investing space white hot. Lilly (NYSE: LLY) will buy ARMO BioSciences Inc. (NASDAQ: ARMO) for $50 a share in an all-cash deal that is nearly triple the price of the Redwood City company's shares when it went public in January. That means big winners amo ng early investors… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - May 11, 2018 Category: American Health Authors: Ron Leuty Source Type: news

CKAP4 Is Novel Serodiagnostic Marker for Lung Cancer
FRIDAY, May 11, 2018 -- Cytoskeleton-associated protein 4 (CKAP4) appears to be a novel serodiagnostic marker for lung cancer, with increased levels in lung cancer patients versus healthy controls, according to a study published online May 8 in The... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 11, 2018 Category: Pharmaceuticals Source Type: news

Minister wants accountability on cervical cancer scandal
It has emerged that at least 208 women diagnosed with cancer should have received earlier intervention. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - May 11, 2018 Category: Consumer Health News Source Type: news

Hope for pancreatic cancer treatment as scientists slow down the tumours with gene editing
Researchers at Imperial College London found removing aggressive molecules called microRNAs  from mouse DNA slowed down the growth of tumours and weakened cancer cells. (Source: the Mail online | Health)
Source: the Mail online | Health - May 11, 2018 Category: Consumer Health News Source Type: news

Dose-Dense Chemo Shows Promise as Neoadjuvant Therapy in Bladder Cancer
A neoadjuvant dose-dense regimen was active and well tolerated in patients with muscle-invasive bladder cancer, allowing downstaging of most patients before radical cystectomy. (Source: CancerNetwork)
Source: CancerNetwork - May 11, 2018 Category: Cancer & Oncology Authors: Dave Levitan Tags: Bladder Cancer Genitourinary Cancers SiteTerms/www.cannabissciencetech.com/News Source Type: news

After 6-month wait, cheques land on doorstep of sick Ontario worker
Mitch LaPrade has been fighting the WSIB for 11 years, arguing his chronic lymphocytic leukemia (CLL) was caused by exposure to a carcinogen called benzene. The highest level of Ontario’s workers’ compensation system ruled in his favour last fall, but his cheques only arrived this week after a CBC investigation. (Source: CBC | Health)
Source: CBC | Health - May 11, 2018 Category: Consumer Health News Tags: News/Canada Source Type: news

Lung cancer symptoms: This feeling in your chest could be a sign YOU have the condition
LUNG cancer symptoms are not always well known, but you should be able to spot the early warning signs in case you, or someone you know, develops the condition. The cancer is one of the two largest killers in the UK. You should be aware of this symptom as a sign of the condition. (Source: Daily Express - Health)
Source: Daily Express - Health - May 11, 2018 Category: Consumer Health News Source Type: news

Cancer Docs: We Need More Research on Medical Marijuana
Title: Cancer Docs: We Need More Research on Medical MarijuanaCategory: Health NewsCreated: 5/10/2018 12:00:00 AMLast Editorial Review: 5/11/2018 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - May 11, 2018 Category: Cancer & Oncology Source Type: news

USPSTF opens review of CT lung screening guidance
The U.S. Preventive Services Task Force (USPSTF) has reopened for review its...Read more on AuntMinnie.comRelated Reading: Stricter CT lung screening criteria deal mixed results CMS says yes to CT lung cancer screening for seniors CT lung screening meeting: A travesty of public health policy Medicare panel raises doubts about CT lung cancer screening USPSTF recommends CT lung cancer screening (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 11, 2018 Category: Radiology Source Type: news

Communicating Measures of Treatment Effect on Survival Communicating Measures of Treatment Effect on Survival
Novel measures, such as mean survival times and net benefit, are suggested for the analysis of phase III oncology trials.Journal of the National Cancer Institute (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 11, 2018 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Cancer treatment developed at Ben-Gurion U. changes cancer cells into normal ones
(American Associates, Ben-Gurion University of the Negev) " Using the siRNA treatment for several types of cancer in mouse models reprogramed cancer cell metabolism, reduced tumor growth and angiogenesis, reduced tumor invasiveness, and induced cancer stem cell disappearance and cell differentiation, " says BGU Prof. Shoshan-Barmatz. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 11, 2018 Category: International Medicine & Public Health Source Type: news

How signals get inside cancer cells and spur aggressive growth
(Michigan Medicine - University of Michigan) A new study provides a surprising model of the process by which signals enter and influence a cancer cell. The finding could open up a potential new avenue to pursue new therapies against cancer. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 11, 2018 Category: International Medicine & Public Health Source Type: news

UCI-Harvard research may help combat the deadly gastrointestinal infection C. diff
(University of California - Irvine) Clostridium difficile   infection is the most common cause of antibiotic-associated diarrhea in developed countries. Researchers have discovered how the C. diff toxin B recognizes the human Frizzled protein, the receptor it uses to invade intestinal cells and lead to deadly gastrointestinal infections. The findings, published in Science, could pave the way for new C. diff antitoxins and also show potential for the development of novel anti-cancer drugs. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 11, 2018 Category: International Medicine & Public Health Source Type: news

Genetic analysis for certain childhood brain tumors soon a standard-of-care?
(German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ)) An international team of researchers from the Hopp Children's Cancer Center at the NCT Heidelberg (KiTZ), the European Molecular Biology Laboratory (EMBL) and the German Cancer Consortium (DKTK) together with colleagues at the St. Jude Children's Research Hospital in Memphis and the Hospital for Sick Children in Toronto has summarized hereditary gene defects which can trigger the development of certain malignant brain tumors (medulloblastoma). From their findings, the team has derived recommendations for routine genetic screening in medulloblastoma pa...
Source: EurekAlert! - Cancer - May 11, 2018 Category: Cancer & Oncology Source Type: news

Scientists screen molecules for promise as new prostate cancer drugs
(University of Bath) Cancer researchers at the University of Bath have measured systematically how efficient molecules are at suppressing the activity of a protein associated with prostate and other cancers. The molecules could eventually be developed into new anti-cancer drugs. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 11, 2018 Category: Cancer & Oncology Source Type: news

Oral drug treatment helps protect cancer patients from potentially deadly blood clots
(University of Warwick) Research from the University of Warwick indicates that taking a tablet a day can help treat cancer patients of a potentially deadly condition. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 11, 2018 Category: Cancer & Oncology Source Type: news

Many patients with rectal cancer may not need chemoradiotherapy
(Wiley) It's unclear whether all patients with advanced rectal cancer need chemoradiotherapy, or whether some can forego the treatment and therefore be spared its side effects. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 11, 2018 Category: Cancer & Oncology Source Type: news

Breast cancer scare recalls the value of collecting evidence
Research and knowledge are not always enough — people must also notice them (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - May 11, 2018 Category: Pharmaceuticals Source Type: news

Big Peninsula biotech buyout means happy returns for Kleiner Perkins, other VCs
A small Peninsula biotech's $1.6 billion buyout by Eli Lilly and Co. would create big Bay Area venture capital winners — including a 50x return for Kleiner Perkins Caufield& Byers — and could turn the cancer immunotherapy investing space white hot. Lilly (NYSE: LLY) will buy ARMO BioSciences Inc. (NASDAQ: ARMO) for $50 a share in an all-cash deal that is nearly triple the price of the Redwood City company's shares when it went public in January. That means big winners amo ng early investors… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 11, 2018 Category: Biotechnology Authors: Ron Leuty Source Type: news

Living With Cancer: Elevated prostate-specific antigen after partial prostate removal
Elevated prostate-specific antigen after partial prostate removal Increased levels of prostate-specific antigen in your blood can be a sign of prostate cancer. However, cancer is just one of several possible causes of increased prostate-specific antigen levels.?After any procedure for an enlarged prostate, a number of factors can cause prostate-specific antigen levels to go up again. [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - May 11, 2018 Category: Databases & Libraries Source Type: news

New system launched to detect and prevent medication errors
Medicines optimisation dashboard will link primary care prescribing data to hospitals admissions Related items fromOnMedica Most nursing home drug errors linked to few serious consequences New pharmacy standards aim to boost patient experience and cut drug errors Multidisciplinary prescribing can help reduce errors Prescription history could help GPs diagnose cancer earlier Over 75s not taking medication correctly, say GPs (Source: OnMedica Latest News)
Source: OnMedica Latest News - May 11, 2018 Category: UK Health Source Type: news

Uveal Effusion Reported After Initiation of Anti - PD - 1, - PD - L1
Case series IDs three patients who developed uveal effusion within one to two months of initiating tx (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - May 11, 2018 Category: Cancer & Oncology Tags: Oncology, Ophthalmology, Pathology, Pharmacy, Journal, Source Type: news

Many Oncologists Discuss, Recommend Medical Marijuana
But majority of oncologists don't feel knowledgeable enough to make these recommendations (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - May 11, 2018 Category: Cancer & Oncology Tags: Family Medicine, Internal Medicine, Nursing, Oncology, Pharmacy, Anesthesiology & amp; Pain, Journal, Source Type: news

Cancer Docs: We Need More Research on Medical Marijuana
(Source: Cancercompass News: Other Cancer)
Source: Cancercompass News: Other Cancer - May 11, 2018 Category: Cancer & Oncology Source Type: news

An emotional call to eradicate cousin of HIV
In an open letter, experts and advocates call for the World Health Organization to implement strategies to eradicate the ancient HTLV-1 virus. One family shares their story of losing a father to cancer caused by the virus. (Source: CNN.com - Health)
Source: CNN.com - Health - May 10, 2018 Category: Consumer Health News Source Type: news

The Stand Up 2 Cancer Colorectal Dream Team
During AACR 2018, Dr. Diaz discusses the progress of his laboratory ’s colorectal cancer research as part of the Stand Up 2 Cancer Colorectal Dream Team. (Source: CancerNetwork)
Source: CancerNetwork - May 10, 2018 Category: Cancer & Oncology Authors: Luis A. Diaz, Jr., MD Tags: Conferences/AACR Street Team News Source Type: news

Big Peninsula biotech buyout means happy returns for Kleiner Perkins, other VCs
A small Peninsula biotech's $1.6 billion buyout by Eli Lilly and Co. would create big Bay Area venture capital winners — including a 50x return for Kleiner Perkins Caufield& Byers — and could turn the cancer immunotherapy investing space white hot. Lilly (NYSE: LLY) will buy ARMO BioSciences Inc. (NASDAQ: ARMO) for $50 a share in an all-cash deal that is nearly triple the price of the Redwood City company's shares when it went public in January. That means big winners amo ng early investors… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - May 10, 2018 Category: Health Management Authors: Ron Leuty Source Type: news

Irish Health Service director resigns amid cancer screening scandal
DUBLIN (Reuters) - The director general of Ireland's Health Service Executive has resigned in the midst of a controversy over a national cervical cancer screening program. (Source: Reuters: Health)
Source: Reuters: Health - May 10, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Half of America's doctors recommend marijuana to cancer patients
Forty-six percent of oncologists suggested it for cancer problems to at least one patient in the past year, the Dana Farber study said. But 56 percent say they do not have the knowledge to do so. (Source: the Mail online | Health)
Source: the Mail online | Health - May 10, 2018 Category: Consumer Health News Source Type: news